Cargando…
Does erythropoietin reactivate bone marrow dysfunction in trauma hemorrhagic shock?
Autores principales: | Kumar, Manoj, Bhoi, Sanjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705567/ https://www.ncbi.nlm.nih.gov/pubmed/26807390 http://dx.doi.org/10.4103/2229-5151.170848 |
Ejemplares similares
-
Hematopoietic stem cells: Can it be a therapeutic option for the hematopoietic failure in patients with trauma-hemorrhagic shock?
por: Kumar, Manoj, et al.
Publicado: (2016) -
Expression of p38 mitogen-activated protein kinases, glycogen synthase kinase, c-Jun NH2-terminal kinase, extracellular signal-regulated kinase signaling: Can it be used as molecular markers among trauma-hemorrhagic shock patients?
por: Kumar, Manoj, et al.
Publicado: (2016) -
Bone marrow hematopoietic stem cells behavior with or without growth factors in trauma hemorrhagic shock
por: Kumar, Manoj, et al.
Publicado: (2016) -
Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?
por: Kumar, Manoj, et al.
Publicado: (2016) -
Alcohol and Drug Testing in the National Trauma Data Bank: Does it Matter?
por: Elkbuli, Adel, et al.
Publicado: (2019)